Vasculitis and Giant Cell Arteritis

Top Story

FDA approves Actemra for giant cell arteritis

FDA approves Actemra for giant cell arteritis
May 22, 2017

The FDA has approved Actemra for the treatment of adults with giant cell arteritis.

“Rheumatologists will finally have available an option for their patients that is going to allow them to discontinue steroids as rapidly as possible,” Christine Birchwood, PhD, senior medical science director from Genentech, told Healio Rheumatology. “It is the first new therapy these patients will have had in more than 50 years.”

Feature

Closer Look at Giant Cell Arteritis

Healio Rheumatology, May 2017
At last year’s American College of Rheumatology Annual Meeting, preliminary results of the GiACTA study made a splash among clinicians who deal with giant cell…
Editorial

Giant Cell Arteritis: What a Long Strange Trip It Has Been

Healio Rheumatology, May 2017
Leonard H. Calabrese, DO
In this issue of Healio Rheumatology, we feature an update on giant cell arteritis as provided by a panel of experts, which charges me with excitement about a disease…
Meeting NewsVideo

VIDEO: Biologics show efficacy, safety in patients with giant cell arteritis

May 11, 2017
DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Robert F. Spiera, MD, from Hospital for Special Surgery, spoke about the need to find a…
CME

Hip Resurfacing Implants: August 2015

Hip resurfacing offers a suitable solution for young patients affected by hip disease who have high function demands…
More »
Video
Meeting News

VIDEO: Biologics show efficacy, safety in patients with giant cell arteritis

May 11, 2017
More »
Featured
Osteoarthritis Research Society International World Congress

Osteoarthritis Research Society International World Congress

CME CNE CPE CE

The Management of Comorbid Conditions in Patients with Rheumatoid Arthritis

Supported by an educational grant from Pfizer Inc.

Strong evidence demonstrates that patients with rheumatoid arthritis (RA) are at a high risk for developing several…
More »
FDA News

FDA approves Actemra for giant cell arteritis

May 22, 2017
The FDA has approved Actemra for the treatment of adults with giant cell arteritis. “Rheumatologists will finally have available an option for…

Feature

Closer Look at Giant Cell Arteritis

Healio Rheumatology, May 2017
At last year’s American College of Rheumatology Annual Meeting, preliminary results of the GiACTA study made a splash among clinicians who deal…

Editorial

Giant Cell Arteritis: What a Long Strange Trip It Has Been

Healio Rheumatology, May 2017
Leonard H. Calabrese, DO
In this issue of Healio Rheumatology, we feature an update on giant cell arteritis as provided by a panel of experts, which charges me with…

Meeting NewsVideo

VIDEO: Biologics show efficacy, safety in patients with giant cell arteritis

May 11, 2017
DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Robert F. Spiera, MD, from Hospital for Special Surgery, spoke about…

Meeting NewsVideo

VIDEO: How to optimize outcomes for patients with ANCA-associated vasculitis

May 10, 2017
DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Carol A. Langford, MD, MHS, spoke about how to optimize outcomes for…

In the Journals

Interferon-alpha led to remission in patients with eosinophilic granulomatosis with polyangiitis

April 26, 2017
Among 30 patients with eosinophilic granulomatosis with polyangiitis, treatment with interferon-alpha led to remission in 25 patients, according to a…

Biosimilars to rituximab, etanercept recommended for approval in Europe

April 21, 2017
The Committee for Medicinal Products for Human Use has recommended approval of biosimilars by Sandoz for rituximab and etanercept for the same…

Meeting News

Langford: Conventional therapy still has a role in granulomatosis with polyangiitis, microscopic polyangiitis

April 11, 2017
CLEVELAND — Conventional therapy still has a role in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis; however…

Meeting News

Calabrese provides a diagnostic update for central nervous system vasculitis

April 11, 2017
CLEVELAND — Leonard H. Calabrese, DO, of the Cleveland Clinic and Chief Medical Editor of Healio Rheumatology, provided a diagnostic…

Meeting NewsVideo

VIDEO: Wechsler talks about role of biologics in eosinophilic granulomatosis with polyangiitis

April 10, 2017
CLEVELAND — At the Biologics Therapies VII Summit, Michael E. Wechsler, MD, MMSc, professor of medicine and director of the Asthma Institute…

More Headlines »
Advertisement
Advertisement